Home / Stocks / BIOA

BIOA insider trading

BioAge Labs, Inc. — open-market insider buys and $1M+ sells from SEC Forms 3, 4 and 5.
Insider buys · 24 mo
4
Bought · 24 mo
$12.5M
Buys · last 90 days
0 · $0
Most recent buy
2025-03-10

Recent insider filings

FiledInsiderTypeSharesPriceValue
2026-07-01Barton Shane
Principal Accounting Officer
Sold42,350$25.21$1.1M
2026-01-15Fortney Kristen
Chief Executive Officer
Sold233,107$18.12$4.2M
2025-03-10Hemrajani Rekha
Director
Bought3,000$18.00$54k
2025-03-10Barton Shane
Principal Accounting Officer
Bought2,632$18.00$47k
2024-10-03Pande Vijay Satyanand
Director
Bought219,195$19.75$4.3M
2024-10-01Chen Bihua
Insider
Bought450,000$18.00$8.1M

Most active insider buyers

InsiderRoleBuysTotal bought
Chen BihuaInsider1$8.1M
Pande Vijay SatyanandDirector1$4.3M
Hemrajani RekhaDirector1$54k
Barton ShanePrincipal Accounting Officer1$47k

See BIOA on the chart

Every insider buy and sell for BIOA plotted on the price, the full two-year history, cluster scores and daily updates — in the members area, $29/month. A free quarterly sample of the whole dataset needs no account.

Open the browserFree sample
Data from the SEC EDGAR ownership filings, refreshed daily. Only open-market purchases (transaction code P) and sales of $1M or more are shown; grants, option exercises and tax withholding are excluded because they run on schedules set years earlier. Not investment advice.